Researchers at the University of Kansas Medical Center, Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center, Brown University School of Public Health, and the University of California San Francisco have introduced a novel immune-profiling method capable of reporting specific immune cell types using only DNA from blood, rather than from fresh cell samples.
Pangea Biomed, a startup developing the Enlight cancer response prediction platform, announced the beginning of a pilot collaboration with the Knight Cancer Institute at Oregon Health and Science University.
